Literature DB >> 19003953

Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice.

Ane Djuv1, Odd Georg Nilsen.   

Abstract

The aims of this study were to carry out a thorough quality control setup for essential Caco-2 cell characteristics in P-glycoprotein (P-gp) inhibition studies and to explore if Aloe vera juice (AVJ) inhibits the bidirectional transport of the P-gp substrate digoxin (30 nm). Seven AVJ concentrations (0.00001-1.0 mg/mL), anticipated to cover a clinically relevant range, were tested and digoxin apparent permeability coefficients (Papp), net Papp values (Papp(Net)) and net flux values (J(Net)) were calculated. Relevant validation parameters for P-gp inhibition studies in Caco-2 cells are suggested to include, as a minimum, an assay linearity test with and without a known P-gp inhibitor, cell cytotoxicity testing (MTT-test) for substrates and inhibitors, and cell integrity testing by TEER and mannitol transport measurements. The question is also raised whether a minimum effect of a reference P-gp inhibitor as verapamil should be demanded. Cell cytotoxicity was seen for digoxin at concentrations >or=3 microM and for AVJ at 10 mg/mL. AVJ did not inhibit the P-gp transport of digoxin in any of the concentrations tested. This indicates that AVJ is no inhibitor of the P-gp mediated transport of digoxin in vitro if AVJ is present in clinically relevant concentrations. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003953     DOI: 10.1002/ptr.2536

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Predicting Impact of Food and Feeding Time on Oral Absorption of Drugs with a Novel Rat Continuous Intestinal Absorption Model.

Authors:  Casey Radice; Ken Korzekwa; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2022-03-26       Impact factor: 3.579

2.  The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study.

Authors:  Ane Djuv; Odd Georg Nilsen; Aslak Steinsbekk
Journal:  BMC Complement Altern Med       Date:  2013-10-30       Impact factor: 3.659

3.  Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations.

Authors:  Daniel Scotcher; Christopher R Jones; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  J Pharmacol Exp Ther       Date:  2017-01-05       Impact factor: 4.030

4.  Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein.

Authors:  Takashi Matsumoto; Noriko Kaifuchi; Yasuharu Mizuhara; Eiji Warabi; Junko Watanabe
Journal:  J Nat Med       Date:  2018-05-24       Impact factor: 2.343

5.  Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.

Authors:  Shinpei Yoshida; Takayuki Honjo; Keita Iino; Ryunosuke Ishibe; Sylvia Leo; Tomoka Shimada; Teruhiko Watanabe; Masaya Ishikawa; Kazuya Maeda; Hiroyuki Kusuhara; Nobuaki Shiraki; Shoen Kume
Journal:  Stem Cell Reports       Date:  2021-01-28       Impact factor: 7.765

6.  Modulation of drug efflux by aloe materials: An In Vitro investigation across rat intestinal tissue.

Authors:  Beneke Carien; Viljoen Alvaro; Hamman Josias
Journal:  Pharmacogn Mag       Date:  2013-10       Impact factor: 1.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.